A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study

[1]  M. Kondratovich,et al.  Patient safety and the next generation of HPV DNA tests. , 2011, American journal of clinical pathology.

[2]  Sin Hang Lee.  Patient safety and the next generation of HPV DNA tests. , 2011, American journal of clinical pathology.

[3]  E. Stanbridge,et al.  Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study , 2010, British Journal of Cancer.

[4]  M. Stoler,et al.  Special commentary: patient safety and the next generation of HPV DNA tests. , 2010, American journal of clinical pathology.

[5]  P. Castle,et al.  Benefits and risks of HPV testing in cervical cancer screening. , 2010, The Lancet. Oncology.

[6]  E. Stanbridge,et al.  Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: A Gynecologic Oncology Group study in United States , 2009, International journal of cancer.

[7]  W. Prendiville,et al.  Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis , 2008, BMJ : British Medical Journal.

[8]  C. Wheeler,et al.  Human Papillomavirus Genotype Specificity of Hybrid Capture 2 , 2008, Journal of Clinical Microbiology.

[9]  C. Wheeler,et al.  A Comparison of Linear Array and Hybrid Capture 2 for Detection of Carcinogenic Human Papillomavirus and Cervical Precancer in ASCUS-LSIL Triage Study , 2008, Cancer Epidemiology Biomarkers & Prevention.

[10]  F. Schmidt.  Meta-Analysis , 2008 .

[11]  Y. Qiao,et al.  Inappropriate gold standard bias in cervical cancer screening studies , 2007, International journal of cancer.

[12]  Diane Solomon,et al.  Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study , 2007, Journal of Clinical Microbiology.

[13]  Jose Jeronimo,et al.  Human papillomavirus and cervical cancer , 2007, The Lancet.

[14]  L. Gaffikin,et al.  Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis , 2007 .

[15]  L. Massuger,et al.  Referral compliance, outcome and predictors of CIN after repeated borderline cervical smears in the Netherlands , 2007, Cytopathology.

[16]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[17]  Francisco A. R. Garcia,et al.  Pilot Study of a Commercialized Human Papillomavirus (HPV) Genotyping Assay: Comparison of HPV Risk Group to Cytology and Histology , 2006, Journal of Clinical Microbiology.

[18]  J. Sorosky,et al.  Clinical Significance of Atypical Glandular Cells on Cervical Cytology , 2006, Obstetrics and gynecology.

[19]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[20]  M. Poljak,et al.  Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  Attila Lorincz,et al.  Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  D C McCrory,et al.  Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. , 2000, American journal of epidemiology.

[23]  V. Seagroatt.  An introduction to medical statistics (2nd ed.) , 1996 .

[24]  L. Tuason,et al.  Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. , 1996, Gynecologic oncology.

[25]  E. Stanbridge,et al.  Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  D. Wilbur.  Endocervical glandular atypia: A “new” problem for the cytologist , 1995, Diagnostic cytopathology.

[27]  E. Manna,et al.  Atypical endocervical glandular cells: Accuracy of cytologic diagnosis , 1995, Diagnostic cytopathology.

[28]  T. Kawana.  [Human papilloma virus and cervical cancer]. , 1990, Gan to kagaku ryoho. Cancer & chemotherapy.

[29]  P. Disaia,et al.  Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. , 1994, The American journal of pathology.

[30]  Y. Fu,et al.  Endocervical Glandular Atypia and Adenocarcinoma: A Correlation of Cytology and Histology , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[31]  G. C. Wei,et al.  A Monte Carlo Implementation of the EM Algorithm and the Poor Man's Data Augmentation Algorithms , 1990 .

[32]  J S Uebersax,et al.  Latent class analysis of diagnostic agreement. , 1990, Statistics in medicine.

[33]  P N Valenstein,et al.  Evaluating diagnostic tests with imperfect standards. , 1990, American journal of clinical pathology.

[34]  S D Walter,et al.  Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. , 1988, Journal of clinical epidemiology.

[35]  Martin Bland,et al.  An Introduction to Medical Statistics , 1987 .

[36]  J. Marx.  Human papilloma virus and cervical cancer. , 1986, Science.

[37]  F. Krauss.  Latent Structure Analysis , 1980 .

[38]  D. Rubin,et al.  Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .

[39]  Paul F. Lazarsfeld,et al.  Latent Structure Analysis. , 1969 .